Literature DB >> 12664049

Intact Medtronic and Carpentier Edwards S.A.V.: clinical and hemodynamic outcomes over 13 years.

A de la Fuente1, R Sánchez, A Imizcoz, J L Fernández, F Olaz, I Moriones.   

Abstract

UNLABELLED: We report on 215 consecutive patients with isolated aortic replacement of which 91 received an Intact Medtronic (IM) prosthesis and 124 a Carpentier Edwards SAV. (CE). More than 50% of patients were over 70 years old. Follow-up was complete for 95% of patients. Mean follow-up was 6.04 years (16 days-13 years); a total of 1244 patient-years (IM 6.61years, 590 patient-years, CE 5.95 years, 670 patient-years).
RESULTS: the following results are expressed for IM and CE groups respectively. Early mortality: 3.3% and 8.13%. Late mortality: 23 and 27 patients. Survival at 13 years: 53.31+/-7.63% and 47.47+/-7.9%. Major thromboembolism: 0.34% and 0.30% per patient-year. SVD: 0.16% and 0.14% per patient-year. Endocarditis: 0.33% and 0.29%. Re-operation: 0.5% and 0.44%. Over 95% of patients are re-operation free at 13 years.
CONCLUSION: Intact and Carpentier valves had similar durability and clinical/hemodynamic results. Both have proved excellent aortic valve substitutes in elderly patients.

Entities:  

Mesh:

Year:  2003        PMID: 12664049     DOI: 10.1016/s0967-2109(03)00010-3

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  2 in total

1.  Comparison of radial deformability of stent posts of different aortic bioprostheses.

Authors:  Martins Kalejs; Romans Lacis; Vladimir Kasyanov; Iveta Ozolanta; Philippe Abdel Sayed; Peteris Stradins; Ludwig Karl von Segesser
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-01

2.  [Safety of biological valves for aortic valve replacement: A systematic review and meta-analysis].

Authors:  B Q Zeng; S Q Yu; Y Chen; W Zhai; B Liu; S Y Zhan; F Sun
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.